Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

BACKGROUND: The incidence of Merkel cell carcinoma (MCC), a rare form of skin cancer with a poor prognosis, has increased in Italy in recent decades. Avelumab, an anti-programmed death ligand 1 monoclonal antibody, is approved for the treatment of metastatic MCC (mMCC) based on the results of the ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Grignani, Giovanni, Chiarion Sileni, Vanna, Pinto, Carmine, Depenni, Roberta, Fazio, Nicola, Galli, Luca, Giuffrida, Dario, Carnaghi, Carlo, Ciliberto, Domenico, Corsi, Domenico C., Queirolo, Paola, Benincasa, Elena, Venturini, Filippo, Fazzi, Gennaro, Costa, Nuno, Ascierto, Paolo Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885451/
https://www.ncbi.nlm.nih.gov/pubmed/33588870
http://dx.doi.org/10.1186/s12967-021-02730-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885451/
https://www.ncbi.nlm.nih.gov/pubmed/33588870
http://dx.doi.org/10.1186/s12967-021-02730-8

Ejemplares similares